title: Eosinophilic folliculitis following allogeneic peripheral blood stem cell transplantation: case report and review.
abstract: Eosinophilic folliculitis is considered a heterogeneous group of disorders, with several clinical subsets, sharing a common histopathological appearance. Increasing numbers of cases, following bone marrow transplantation (BMT), have been reported in recent years. We herein present a case of eosinophilic folliculitis that appeared in a 26-year-old woman 5 months after allogeneic peripheral blood stem cell transplantation as treatment for eosinophilic acute leukemia. Our review of the published cases has shown that eosinophilic folliculitis in patients after BMT could be considered as a pattern of reaction related to immune dysregulation.
authors.affiliation: Department of Dermatology, Hospital Universitario La Princesa, Madrid, Spain. rebecagv@aedv.es
authors.forename: Rebeca
authors.initials: R
authors.lastname: Goiriz
authors.forename: Guillermo
authors.initials: G
authors.lastname: Guhl-Millán
authors.forename: Pablo F
authors.initials: PF
authors.lastname: Peñas
authors.forename: Jesús
authors.initials: J
authors.lastname: Fernández-Herrera
authors.forename: Esteban
authors.initials: E
authors.lastname: Daudén
authors.forename: Javier
authors.initials: J
authors.lastname: Fraga
authors.forename: Amaro
authors.initials: A
authors.lastname: García-Diez
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D004802:Eosinophilia / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D005260:Female; D005499:Folliculitis / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D006801:Humans; D015472:Leukemia, Eosinophilic, Acute / Q000628:therapy; D036102:Peripheral Blood Stem Cell Transplantation / Q000009:adverse effects*; D011241:Prednisone / Q000627:therapeutic use; D014184:Transplantation, Homologous; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D011241:Prednisone